Short-Term Investments
Moderna Short-Term Investments increased by 2.9% to $3.3B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.2%, from $4.35B to $3.3B. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows an upward trend with a 10.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates the company is effectively deploying excess cash to earn returns, while a decrease may signal the use of these funds for operations or capital expenditures.
Detailed definition
These are marketable securities and other financial instruments that are expected to be converted into cash within one y...
Peer comparison
Common in cash-rich companies; peers in the biotech sector often hold significant short-term investments to fund multi-year clinical pipelines.
short_term_investmentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.39B | $3.36B | $3.88B | $5.07B | $5.02B | $5.32B | $6.7B | $5.48B | $4.66B | $4.64B | $5.7B | $6.47B | $6.01B | $5.22B | $5.1B | $4.35B | $3.85B | $3.37B | $3.2B | $3.3B |
| QoQ Change | — | +40.6% | +15.6% | +30.6% | -0.8% | +5.9% | +25.9% | -18.1% | -15.0% | -0.4% | +22.8% | +13.6% | -7.1% | -13.1% | -2.4% | -14.6% | -11.5% | -12.5% | -5.0% | +2.9% |
| YoY Change | — | — | — | — | +110.5% | +58.6% | +72.6% | +8.2% | -7.3% | -12.8% | -14.9% | +18.1% | +29.0% | +12.5% | -10.5% | -32.8% | -35.9% | -35.4% | -37.2% | -24.2% |
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Moderna's short-term investments?
- Moderna (MRNA) reported short-term investments of $3.3B in Q1 2026.
- How has Moderna's short-term investments changed year-over-year?
- Moderna's short-term investments decreased by 24.2% year-over-year, from $4.35B to $3.3B.
- What is the long-term trend for Moderna's short-term investments?
- Over 5 years (2020 to 2025), Moderna's short-term investments has grown at a 10.1% compound annual growth rate (CAGR), from $1.98B to $3.2B.
- What does short-term investments mean?
- Financial investments that can be easily converted to cash within a year.